AI-FAI demonstrates favorable agreement with traditional workstation-FAI, solid diagnostic performance, and consistent cross-scanner robustness, providing a reliable automated tool for cardiovascular risk assessment.
Abstract
Objectives
To evaluate the feasibility and generalizability of an AI-based automated method for measuring the pericoronary fat attenuation index (FAI)-a promising non-invasive imaging biomarker for coronary inflammation-and to promote efficient clinical translation.
Methods
A retrospective analysis was conducted on coronary computed tomography angiography data from 1,125 patients (584 [51.9%] male; mean age 61.5 ± 12.3 years; totaling 3,375 coronary arteries) examined using five mainstream CT scanners from different manufacturers, models, and generations. FAI values around the major coronary arteries were quantitatively evaluated using both AI software and workstation. Agreement between methods, diagnostic performance, and scanner influence were assessed.
Results
Artificial intelligence-based fat attenuation index (AI-FAI) demonstrated a favorable correlation with workstation-FAI at the patient level (ρ = 0.877, p < 0.001; n = 1,125), along with a high level of agreement (mean bias: 1.60 HU; 95% limits of agreement: -4.94 to 8.14; 94.84% within limits). Using a threshold of -70.1 HU, AI-FAI demonstrated performance comparable to workstation-FAI, with accuracy (84.98%) and solid diagnostic performance (AUC = 0.851). Furthermore, AI-FAI exhibited stable measurement performance across all five scanners, with inter-scanner ρ ranging from 0.829 to 0.896 and only 3.70-6.06% of outliers beyond the agreement limits.
Conclusions
AI-FAI demonstrates favorable agreement with traditional workstation-FAI, solid diagnostic performance, and consistent cross-scanner robustness, providing a reliable automated tool for cardiovascular risk assessment.
ADVANCES IN KNOWLEDGE
This is a novel study demonstrating AI-FAI as a practical alternative to workstation-FAI across multiple CT scanners, facilitating reliable quantification of coronary inflammation for routine clinical practice.
Artificial intelligence-based quantitative assessment of LGE is an independent predictor of adverse cardiovascular outcomes in patients with HCM and may represent a clinically meaningful imaging biomarker for risk stratification.
Youngsang Jeong, Jong-Il Park, Kang-Un Choi et al.· The Korean Journal of Intern...· 0 citations
Coronary computed tomography angiography (CCTA) has evolved from an anatomical test into a platform for cardiovascular risk phenotyping. Pericoronary adipose tissue (PCAT), which is directly contiguous with the coronary adventitia, changes its composition in response to vascular inflammation and can be interrogated on...
V. Hoang, V. Chansomphou, C. Trinh· BioMed Research Internationa...· 0 citations
Fat attenuation index (FAI) is currently used in research on coronary atherosclerotic heart disease, but there are no reports on FAI applications in coronary artery spasm (CAS). In this study, we explored the association between pericoronary FAI and CAS. Patients who had chest pain and stenosis < 50% in major coronary...
Chen Yu, Zhen-Qiang Sheng, Lei Li et al.· Medicine· 0 citations
This study aimed to evaluate the clinical performance of artificial intelligence (AI)-assisted measurement of thoracic aortic diameter on non-contrast computed tomography (NCCT). This single-center prospective study included 79 patients (mean age = 70 ± 13 standard deviation; 46 men) who underwent NCCT and arterial pha...
Akiyoshi Suzuki, N. Tomizawa, Kotaro Yamamoto et al.· Medicine· 0 citations
To assess the clinical impact of an artificial intelligence (AI)-based software-as-a-medical-device (SaMD) for acute aortic syndrome (AAS) detection on computed tomography angiography (CTA), and validate its effect on diagnostic accuracy in a multicenter reader study. In this retrospective study, 205 CTA scans (101...
Chih-Wei Huang, Chun-Chao Chen, Joseph Chang et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.